These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20646898)

  • 1. Evaluation of the role of the critical care pharmacist in identifying and avoiding or minimizing significant drug-drug interactions in medical intensive care patients.
    Rivkin A; Yin H
    J Crit Care; 2011 Feb; 26(1):104.e1-6. PubMed ID: 20646898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
    MacLaren R; Bond CA
    Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proactive palliative care in the medical intensive care unit: effects on length of stay for selected high-risk patients.
    Norton SA; Hogan LA; Holloway RG; Temkin-Greener H; Buckley MJ; Quill TE
    Crit Care Med; 2007 Jun; 35(6):1530-5. PubMed ID: 17452930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of a pharmacy resident on hospital length of stay and drug-related costs.
    Terceros Y; Chahine-Chakhtoura C; Malinowski JE; Rickley WF
    Ann Pharmacother; 2007 May; 41(5):742-8. PubMed ID: 17440008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of a clinical pharmacist-enforced intensive care unit sedation protocol on duration of mechanical ventilation and hospital stay.
    Marshall J; Finn CA; Theodore AC
    Crit Care Med; 2008 Feb; 36(2):427-33. PubMed ID: 18091554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of pharmacist contribution to an oncology ward in a Swedish hospital.
    Bremberg ER; Hising C; Nylén U; Ehrsson H; Eksborg S
    J Oncol Pharm Pract; 2006 Jun; 12(2):75-81. PubMed ID: 16984745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the clinical pharmacist in reducing mortality in hospitalized cardiac patients: A prospective, nonrandomized controlled trial using propensity score methods.
    Zhai XB; Tian DD; Liu XY
    Int J Clin Pharmacol Ther; 2015 Mar; 53(3):220-9. PubMed ID: 25546163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacist monitoring of QTc interval-prolonging medications in critically ill medical patients: a pilot study.
    Ng TM; Bell AM; Hong C; Hara JM; Touchette DR; Danskey KN; Lindsay TT; Puumala SE
    Ann Pharmacother; 2008 Apr; 42(4):475-82. PubMed ID: 18319393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors for mortality following interhospital transfers to the medical intensive care unit of a tertiary referral center.
    Durairaj L; Will JG; Torner JC; Doebbeling BN
    Crit Care Med; 2003 Jul; 31(7):1981-6. PubMed ID: 12847392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feeding practices of severely ill intensive care unit patients: an evaluation of energy sources and clinical outcomes.
    Hise ME; Halterman K; Gajewski BJ; Parkhurst M; Moncure M; Brown JC
    J Am Diet Assoc; 2007 Mar; 107(3):458-65. PubMed ID: 17324665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High occupancy increases the risk of early death or readmission after transfer from intensive care.
    Chrusch CA; Olafson KP; McMillan PM; Roberts DE; Gray PR
    Crit Care Med; 2009 Oct; 37(10):2753-8. PubMed ID: 19707139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medication reconciliation in a rural trauma population.
    Miller SL; Miller S; Balon J; Helling TS
    Ann Emerg Med; 2008 Nov; 52(5):483-91. PubMed ID: 18550221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visits to intensive care unit patients--frequency, duration and impact on outcome.
    Eriksson T; Bergbom I
    Nurs Crit Care; 2007; 12(1):20-6. PubMed ID: 17883660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Provision of pharmaceutical care in the intensive care unit.
    Kilroy RA; Iafrate RP
    Crit Care Nurs Clin North Am; 1993 Jun; 5(2):221-5. PubMed ID: 8398030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effectiveness of a critical care nursing outreach service in facilitating discharge from the intensive care unit.
    Williams TA; Leslie G; Finn J; Brearley L; Asthifa M; Hay B; Laurie K; Leen T; O'Brien K; Stuart M; Watt M
    Am J Crit Care; 2010 Sep; 19(5):e63-72. PubMed ID: 20810409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Even in best-run centers, preventable medication errors lengthen LOS, increase costs.
    Health Care Cost Reengineering Rep; 1998 Oct; 3(10):149-51. PubMed ID: 10186033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing medication errors in the neonatal intensive care unit.
    Simpson JH; Lynch R; Grant J; Alroomi L
    Arch Dis Child Fetal Neonatal Ed; 2004 Nov; 89(6):F480-2. PubMed ID: 15499135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of adverse drug events and hospital-related morbidity and mortality among older adults with potentially inappropriate medication use.
    Page RL; Ruscin JM
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):297-305. PubMed ID: 17296535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of pharmacists' intervention on identification and management of drug-drug interactions in an intensive care setting.
    Hasan SS; Lim KN; Anwar M; Sathvik BS; Ahmadi K; Yuan AW; Kamarunnesa MA
    Singapore Med J; 2012 Aug; 53(8):526-31. PubMed ID: 22941130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospital mortality rate and length of stay in patients admitted at night to the intensive care unit.
    Morales IJ; Peters SG; Afessa B
    Crit Care Med; 2003 Mar; 31(3):858-63. PubMed ID: 12626997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.